Immuron (IMRN) Asset Utilization Ratio (2019 - 2024)
Immuron (IMRN) posted quarterly Asset Utilization Ratio of 2.66 for Q4 2024, up 587.17% year-on-year from 0.39 in Q1 2024, and up 587.17% on a QoQ basis from 0.39 in Q4 2023.
Immuron (IMRN) Asset Utilization Ratio (2019 - 2024) Analysis & Trends
Immuron (IMRN) has reported Asset Utilization Ratio for 5 consecutive years, with 2.66 the latest figure, recorded in Q4 2024.
- Quarterly Asset Utilization Ratio rose 587.17% year-over-year to 2.66 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 2.66 (up 587.17% YoY) and the FY2025 annual result came in at 1.41, up 527.59% from the prior year.
- Asset Utilization Ratio grew to 2.66 in Q4 2024 per IMRN's latest filing, from 0.39 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for IMRN reached as high as 2.66 in Q4 2024 and fell as low as 0.08 in Q2 2023.
- A 4-year average of 0.73 and a median of 0.35 in 2021 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio plunged 51.51% — and 2024, when it surged 587.17%.
- Year by year, Asset Utilization Ratio stood at 0.35 in 2021, then tumbled by 51.51% to 0.17 in 2022, then jumped by 128.26% to 0.39 in 2023, then jumped by 587.17% to 2.66 in 2024.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 2.66, 0.39, and 0.08 for Q4 2024, Q4 2023, and Q2 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2.66 |
| Dec 31, 2023 | 0.39 |
| Jun 30, 2023 | 0.08 |
| Dec 31, 2022 | 0.17 |
| Dec 31, 2021 | 0.35 |
| Dec 31, 2019 | 1.16 |